UMN Pharma prolongs examination period for recombinant influenza vaccine

The multivalent vaccine ASP7374 which will be sold by Astellas is manufactured in insect cell lines.

UMN Pharma news release, Sept. 30, 2016

UMN Pharma prolongs examination period for recombinant influenza vaccine
Scroll to top